Analysis Of Income And Expense [Abstract]

GenSight Biologics S.A. - Filing #855040

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Analysis of income and expense [abstract]
Material income and expense [abstract]
Research and development expense
19,343,000 EUR
22,920,000 EUR
Finance income (cost)
215,000 EUR
489,000 EUR
Selling, general and administrative expense [abstract]
General and administrative expense
5,361,000 EUR
7,411,000 EUR
Revenue and other operating income
4,865,000 EUR
7,709,000 EUR
Operating expense
32,700,000 EUR
35,835,000 EUR
Sales and marketing expense
7,996,000 EUR
5,505,000 EUR
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
174,000 EUR
174,000 EUR
215,000 EUR
215,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
27,625,000 EUR
124,000 EUR
27,748,000 EUR
28,617,000 EUR
207,000 EUR
28,824,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.